Ausgabe 2/2007
Inhalt (19 Artikel)
Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol
J. D. Ringe, E. Schacht
Antigen specificity of antihistone antibodies in connective tissue disease patients with anti-U1RNP antibodies
Takamasa Wayaku, Minoru Hasegawa, Kenzo Kaji, Miki Kondo, Yuki Saito, Hidemitsu Orito, Mayuka Horikawa, Takashi Matsushita, Kazuhiro Komura, Ikuko Hayakawa, Yasuhito Hamaguchi, Fumihide Ogawa, Manabu Fujimoto, Kazuhiko Takehara, Shinichi Sato
Tumor necrosis factor alpha −308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China
Ruiwen Chen, Meng Fang, Qing Cai, Shiwei Duan, Ke Lv, Ning Cheng, Daming Ren, Jie Shen, Dongyi He, Lin He, Shuhan Sun
EGF activates PI3K-Akt and NF-κB via distinct pathways in salivary epithelial cells in Sjögren’s syndrome
Hideki Nakamura, Atsushi Kawakami, Hiroaki Ida, Takehiko Koji, Katsumi Eguchi
Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis
Yasunori Kageyama, Tetsuya Ichikawa, Tetsuyuki Nagafusa, Eiji Torikai, Masahiro Shimazu, Akira Nagano
Microvascular dysfunction in rheumatoid arthritis assessed by laser Doppler anemometry: relationship to soluble adhesion molecules and extraarticular manifestations
Martin F. Meyer, Olga Schmidt, Bernhard Hellmich, Helmut Schatz, Harald H. Klein, Jürgen Braun
Safety and efficacy of once-weekly application of Etanercept in children with juvenile idiopathic arthritis
Jasmin B. Kuemmerle-Deschner, Gerd Horneff
Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods
Tomoko Matsumoto, Toshiyuki Tsurumoto, Hideo Baba, Makoto Osaki, Hiroshi Enomoto, Akihiko Yonekura, Hiroyuki Shindo, Toshio Miyata
The association of DRB1*04 share epitope alleles and tumor necrosis factor-alpha gene polymorphism (−863) with susceptibility to rheumatoid arthritis in Thai
N. Hirankarn, J. Nakkuntod, P. Duangchalermwong, U. Deesomchok, P. Charoenwongse
A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype
Dimitrios Zonios, Clio P. Mavragani, Stavros Giaglis, Konstatinos Ritis
Antiphospholipid syndrome: a predisposing factor for early onset HELLP syndrome
Panagiotis Tsirigotis, George Mantzios, Vassiliki Pappa, Konstantinos Girkas, George Salamalekis, Angellos Koutras, Vassiliki Giannopoulou, Konstantina Spirou, Alexia Balanika, Sotirios Papageorgiou, Anthi Travlou, John Dervenoulas
Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjögren’s syndrome
Pascal Sève, Emilie Gachon, Philippe Petiot, Katia Stankovic, Annick Charhon, Christiane Broussolle
Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma
Zs. Simon, T. Tarr, Zs. Ress, L. Gergely, E. Kiss, A. Illes
Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis
Kenan Aksu, Ayhan Donmez, Yesim Ertan, Gokhan Keser, Vedat Inal, Gonca Oder, Murat Tombuloglu, Yasemin Kabasakal, Eker Doganavsargil
Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis
Zahra Rezaieyazdi, Jalil Tavakol Afshari, Mahnaz Sandooghi, Farnaz Mohajer
A probe into the HLA-DR and DQ of Arab patients with primary antiphospholipid (Hughes) syndrome
Haider M. Al Attia, Anitha Santhosh
TNF inhibitors for ankylosing spondylitis in the real world
Claire M. McVeigh, Aubrey L. Bell, Andrew P. Cairns
Successful treatment with infliximab of refractory rheumatoid arthritis in a male with ‘GDF5 brachydactyly’
Takeshi Suzuki, Zen-ichiro Honda